Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

Tempest Therapeutics, Inc. (TPST)

NASDAQ

$1,08

$+0,30

(+40,32%)

Pre-Market

Tempest Therapeutics, Inc. (TPST) Live Price Chart

Last updated: ⁦2026-09-16 13:27:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Tempest Therapeutics, Inc. (TPST) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,08, with a market capitalization of $12,97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,74 to $6,12. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$12,97M
Open	$1,24
Day's High	$266,50
Day's Low	$0,74
Previous Close	$0,76
Volume	21,94M
Average Volume	650,23K
P/E Ratio	--
52-Week High	$6,12
52-Week Low	$0,74
Dividend Yield	--
Earnings Date	--

Tempest Therapeutics, Inc. (TPST) Pre-Market Stock Price

Tempest Therapeutics, Inc. (TPST) is trading at $1,08 in pre-market trading as of 2026-09-16 13:25:00, up 42,31% ($0,32) from the previous close of $0,76

Pre-market trading shows how investors are pricing TPST before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Tempest Therapeutics, Inc. (TPST) 7-Day Stock Price Change

Over the past seven days, Tempest Therapeutics, Inc. (TPST) moved from $1,03 to $1,08, representing a gain of 4,37% ($0,04).

The stock traded between $0,74 and $1,27 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 4,05 million shares, up versus the previous seven-day period, indicating higher trading activity.

TPST 52-Week Price Position

Position in Range: 6,2%

52W Low$0,74

52W High$6,12

TPST is currently trading at $1,08, placing it 6,2% of the way from its 52-week low of $0,74 to its 52-week high of $6,12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Tempest Therapeutics, Inc. (TPST)?

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.

Tempest Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	4
Exchange	NASDAQ
Company Website	https://www.tempesttx.com

How to Buy Tempest Therapeutics, Inc. (TPST) Stock on MEXC

Eligible investors can buy real shares of Tempest Therapeutics, Inc. (TPST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TPST and Place Your Order

Open the RealStocks trading page and search for TPST. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Tempest Therapeutics, Inc. (TPST) stock price today?

Tempest Therapeutics, Inc. (TPST) is currently trading at $ 1,08, up 42,31% ($0,32) from the previous close of $ 0,76. Intraday prices update in real time during regular trading hours.

2.Is TPST stock going up or down today?

As of 2026-09-16 13:25:00, TPST is trading at $ 1,08, up 42,31% ($0,32) from its previous close of $ 0,76. The stock has traded between $ 0,74 and $ 266,50 during today’s regular session. Past price movements do not guarantee future results.

3.What is TPST pre-market price?

As of 2026-09-16 13:25:00, TPST is trading at $ 1,08 in pre-market trading, up 42,31% ($0,32) from the previous close of $ 0,76. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TPST after-hours price?

As of 2026-09-16 13:25:00, TPST is trading at $ 1,21 in after-hours trading, up 60,71% ($0,46) from the regular-session close of $ 0,76. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TPST stock trading now?

TPST trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TPST sit relative to its 52-week high and low?

Over the past 52 weeks, TPST has traded between a low of $ 0,74 and a high of $ 6,12. At $ 1,08, the stock is positioned 6,2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Tempest Therapeutics, Inc. in?

Tempest Therapeutics, Inc. (TPST) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Tempest Therapeutics, Inc.'s market capitalization and where is it listed?

Tempest Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 12,97M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TPST valued in terms of P/E ratio and EPS?

TPST trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2,45. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Tempest Therapeutics, Inc. pay a dividend?

Tempest Therapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.